It was a positive week for the European Medicines Agency’s human medicines committee (CHMP), which recommended the approval of eight new drugs including Takeda’s Fruzaqla and AstraZeneca’s Truqap.
The committee also voted in favor of six new label expansions. While the European Commission has the final…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
